Versant Venture Management

Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RYZB, CRSP, RPTX, GRTS, PASG, and represent 98.62% of Versant Venture Management's stock portfolio.
  • Reduced shares in these 1 stock: Minerva Surgical.
  • Sold out of its position in Minerva Surgical.
  • Versant Venture Management was a net seller of stock by $-275k.
  • Versant Venture Management has $389M in assets under management (AUM), dropping by 106.71%.
  • Central Index Key (CIK): 0001560009

Tip: Access up to 7 years of quarterly data

Positions held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Versant Venture Management

Versant Venture Management holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
RayzeBio Common Stock (RYZB) 82.5 $321M 5.2M 62.17
 View chart
CRISPR Therapeutics Common Shares (CRSP) 8.0 $31M 499k 62.60
 View chart
Repare Therapeutics Common Stock (RPTX) 5.0 $19M 2.6M 7.30
 View chart
Gritstone Bio Common Stock (GRTS) 1.9 $7.3M 3.6M 2.04
 View chart
Passage Bio Common Stock (PASG) 1.3 $5.0M 5.0M 1.01
 View chart
Adverum Biotechnologies Common Stock (ADVM) 1.0 $3.8M 5.1M 0.75
 View chart
Aligos Therapeutics Common Stock (ALGS) 0.4 $1.5M 2.3M 0.66
 View chart

Past Filings by Versant Venture Management

SEC 13F filings are viewable for Versant Venture Management going back to 2014

View all past filings